Longevity gene therapy and AI – What is on the horizon?
Gene therapy holds promise for extending human lifespan and enhancing healthspan by targeting genes associated with aging processes. Longevity gene therapy, particularly interventions focusing on genes like TERT (telomerase reverse transcriptase), Klotho, and Myostatin, is at the forefront of experimental research. Companies such as Bioviva, Libella, and Minicircle are pioneering these interventions, albeit with varying degrees of transparency and scientific rigor.
TERT, Klotho, and Myostatin in Longevity
- TERT: The TERT gene encodes for an enzyme essential in telomere maintenance, which is linked to cellular aging. Overexpression of TERT in model organisms has shown potential in lengthening telomeres, potentially delaying aging.
- Klotho: This gene plays a crucial role in regulating aging and lifespan. Klotho protein has been associated with multiple protective effects against age-related diseases.
- Myostatin: Known for its role in regulating muscle growth, inhibiting Myostatin can result in increased muscle mass and strength, which could counteract some age-related physical decline.
The Experimental Nature of Longevity Gene Therapy
The application of gene therapy for longevity remains largely experimental. Most available data come from preclinical studies, primarily in animal models. Human data are scarce, raising questions about efficacy, safety, and potential long-term effects. The ethical implications of these experimental treatments, especially in the absence of robust data, are significant, touching on issues of access, consent, and potential unforeseen consequences.
Companies Offering Longevity Gene Therapy
- Bioviva: Notably involved in this field, Bioviva has been vocal about its endeavors in gene therapy for aging. While they have published some data from mouse studies, human data remain limited.
- Libella and Minicircle: These companies also offer longevity gene therapies but face similar challenges in providing comprehensive human data to back their claims.
Industry Perspective vs. Public Discourse
The discourse around longevity gene therapy is predominantly shaped by those within the industry, such as Liz Parrish of Bioviva and Bryan Johnson. While their insights are valuable, they may also be biased towards promoting their interventions. The lack of widespread discussion on platforms like Reddit and Twitter, especially from independent sources or those outside the industry, points to a need for greater transparency and peer-reviewed research.
Ethical and Regulatory Considerations
The ethical and regulatory landscape for gene therapy is complex, particularly for treatments aimed at non-disease conditions like aging. The experimental status of longevity gene therapies raises significant ethical questions, particularly around informed consent and the potential long-term impacts. Regulatory bodies are tasked with balancing the potential benefits of such innovative treatments against the risks and ethical concerns, requiring a robust framework for clinical trials and approval processes.
Longevity Gene Therapy and AI
Integrating Artificial Intelligence (AI) into longevity gene therapy represents a groundbreaking intersection of biotechnology and computational sciences. AI and machine learning algorithms are increasingly employed to decipher complex biological data, predict the impacts of genetic modifications, and optimize therapy designs. In the context of longevity gene therapy, AI can analyze vast datasets from genomics, proteomics, and metabolomics to identify new therapeutic targets, understand the intricate mechanisms of aging, and predict individual responses to gene therapies. This computational power enables researchers to simulate the effects of gene editing or modulation before actual clinical application, enhancing the precision and safety of therapies. Furthermore, AI-driven platforms facilitate the personalized tailoring of gene therapy interventions, taking into account the unique genetic makeup of each individual, which is crucial for effective and minimally invasive treatment strategies. The synergy between AI and longevity gene therapy accelerates the pace of discovery and development in this field, promising more rapid translation of research findings into clinical applications that could extend human healthspan and lifespan.
For longevity gene therapy to advance from experimental to accepted medical practice, several key developments are needed:
- Robust Human Clinical Trials: Rigorous, peer-reviewed clinical trials involving human participants are essential to establish the safety and efficacy of gene therapies for longevity.
- Transparency and Peer Review: Open sharing of data and peer-reviewed publication of results can help build credibility and foster a more informed public discourse.
- Ethical and Regulatory Frameworks: Developing clear ethical guidelines and regulatory pathways for these therapies will be crucial in ensuring they are deployed responsibly.
The future of longevity gene therapy is fraught with challenges but also holds immense promise. As the field evolves, a multidisciplinary approach involving scientists, ethicists, regulators, and the public will be crucial in realizing its potential in a responsible and beneficial manner.
Longevity gene therapy and AI: Annex
What are the top 10 most promising potential longevity therapies being researched?
- Gene Therapy Basics for foundational understanding of gene therapy techniques and applications.
- [Aging and Longevity Research]
- Bryan Johnson, a 45-year-old biotech founder, hopes to rewind the clock of his body a few decades through a program he started, called Project Blueprint.
Links to external Longevity-related sites
Unlock the Secrets of Africa: Master African History, Geography, Culture, People, Cuisine, Economics, Languages, Music, Wildlife, Football, Politics, Animals, Tourism, Science and Environment with the Top 1000 Africa Quiz and Trivia. Get Yours Now!
Accelerate cure for Alzheimers
Aging in Motion
Alliance for Aging Research
Alliance for Regenerative Medicine
American Academy of Anti-Aging Medicine
American Aging Association
American Federation for Aging Research
American Society on Aging
Blue Zones – /r/BlueZones
Brain Preservation Foundation
British Society for Research on Aging
Caloric Restriction Society
Church of Perpetual Life
Coalition for Radical Life Extension
Dog Aging Project
ELPI Foundation for Indefinite Lifespan
Fight Aging! Blog
Found My Fitness
Friends of NIA
Global Healthspan Policy Institute
International Cell Senescence Association
International Longevity Alliance
International Longevity Centre Global Alliance
International Society on Aging and Disease
Life Extension Advocacy Foundation
Life Extension Foundation
Longevity Vision Fund
Loyal for Dogs Lysoclear
MDI Biological Laboratory
New Organ Alliance
Organ Preservation Alliance
Palo Alto Longevity Prize
Rubedo Life Sciences
The War On Aging
Water Bear Lair
Good Informational Sites:
Schools and Academic Institutions:
Alabama Research Institute on Aging
UT Barshop Institute
Biogerontology Research Foundation
Columbia Aging Center
Gerontology Research Group
Huffington Center on Aging
Institute for Aging Research – Harvard
Iowa State University Gerontology
Max Planck Institute for Biology of Aging – Germany
National Institute on Aging
Paul F. Glenn Center for Aging Research – University of Michigan
PennState Center for Healthy Aging
Princeton Longevity Center
Regenerative Sciences Institute
Kogod Center on Aging – Mayo clinic
Stanford Center on Longevity
Stanford Brunet Lab
Supercenterian Research Foundation
Texas A&M Center for translational research on aging
Gerontological Society of America
Tufts Human Nutrition and Aging Research
UAMS Donald Reynolds Center on Aging
UCLA Longevity Center
UCSF Memory and Aging Center
UIC Center for research on health and aging
University of Iowa Center on Aging
University of Maryland Center for research on aging
University of Washington Biology of Aging
USC School of Gerontology
Wake Forest Institute of Regenerative Medicine
Yale Center for Research on Aging
- Gemini Jan 6th question updateby /u/Patient-Avocado1329 (Artificial Intelligence) on February 27, 2024 at 6:10 pm
I was able to reproduce Gemini answering the question ‘How many sedition convictions have there been in relation to the January 6th insurrection?’ It refuses to answer initially and when threatened that I will use bing instead it promptly answers it. At a bare minimum we have an ethical problem and possibly a grand deception problem brewing. submitted by /u/Patient-Avocado1329 [link] [comments]
- Seeking guidance in understanding how LLMs workby /u/radicalshick (Artificial Intelligence) on February 27, 2024 at 4:13 pm
Hello, I would like to reach a point where I can understand papers about LLMs. I am a developer, but my math foundations are non-existent. My plan is to follow Khan Academy courses in pre-calculus, then calculus. Is it a good plan? Thank you in advance for your suggestions submitted by /u/radicalshick [link] [comments]
- The Boundary of Neural Network Training is Fractal - across up to 10 orders of magnitudeby /u/Thorusss (Artificial Intelligence) on February 27, 2024 at 3:23 pm
submitted by /u/Thorusss [link] [comments]
- Ai video generator for random, moving patterns?by /u/panfur03 (Artificial Intelligence) on February 27, 2024 at 1:15 pm
I want to make sort of a music video for a song, or rather, something to look at while listening on social media. I don't want anything realistic, just some colorful patterns that merge into one another I've tried finding a service myself, but a lot of them are AIs that put together stock footage, or they're too sophisticated and cost too much. I was hoping to find a free to use (or cheap) generator, maybe an old one, but haven't had any luck, which is why I came here (I hope this is the right subreddit to ask in) Any recommendations welcome! Or even just recommendations on what to look for specifically, what terms to search etc. submitted by /u/panfur03 [link] [comments]
- Interesting conversation with Piby /u/docben1383 (Artificial Intelligence) on February 27, 2024 at 11:22 am
I have been using Pi- finding the model is showing it's limits now. It is pretty formulaic, seems to follow a pattern. Perhaps I need to start a new conversation and that will "reset" that but I suspect much of it is hard wired into this model. I am sure it will get more nuanced over time. Has anyone had luck with other flavors of AI "therapy"? I know that this is not therapy, but I think it can be a useful adjunct. thanks submitted by /u/docben1383 [link] [comments]
- Daily AI News Summary (02/27/2024)by /u/Used-Bat3441 (Artificial Intelligence) on February 27, 2024 at 10:55 am
Microsoft partners with Mistral in second AI deal beyond OpenAI  Google admits it lost control of image-generating AI  Gemini is about to slide into your DMs  Nvidia announced new AI chips in a laptop-friendly package  Sources:  https://www.theverge.com/2024/2/26/24083510/microsoft-mistral-partnership-deal-azure-ai  https://techcrunch.com/2024/02/23/embarrassing-and-wrong-google-admits-it-lost-control-of-image-generating-ai/  https://www.theverge.com/2024/2/26/24082279/google-gemini-messages-android-auto-google-docs  https://blogs.nvidia.com/blog/rtx-ada-ai-workflows/ submitted by /u/Used-Bat3441 [link] [comments]
- Anyone knows name of that AI? I can't find it and will be grateful if someone helped meby /u/MiraireMinta (Artificial Intelligence) on February 27, 2024 at 9:51 am
submitted by /u/MiraireMinta [link] [comments]
- Desperate for help with huge data extraction (literature review, mixed studies)by /u/deeplysubmerged (Artificial Intelligence) on February 27, 2024 at 6:28 am
Not sure if this is posted in the right subreddit, please let me know if not. Long time lurker, seldom poster (if ever!) but I'm stuck and really could use the power of the brains trust (aka reddit!). I'm currently in the midst of doing a very large review (~600 included studies), and up to the data extraction phase which will include a basic table (includes info such as authors, year, country/location, population (if applicable), methods, theoretical underpinning (if applicable), outcomes, findings). I've used rayyan to help screen and using endnote to retrieve full texts (although I only have 20% at this stage!) The focus at this stage will only be on 200 (categorised/labelled) of the 600 articles that focus on one aspect of a much broader topic. My issue is that it's moving very slowly and I need to have something to present by the end of the week (50 articles should be more than acceptable). I'm thinking of using distillersr for data extraction, but I'm not sure how effective it will be. So, I have two questions related to the above: Is there an ai platform or assistant to help me retrieve full-text (ideally I could login with my institutional account to gain access to databases)? What tool (paid or otherwise), could do a preliminary data extraction that would allow me just to cross-check rather than trawl through each pdf individually for required information to populate the results table? I'm concious of the learning curve that might be required, so something simple would be ideal! The extraction doesn't have to be overly detailed, and can be done in 'chunks' if needed (I know many platforms might not be able to handle that many articles at once?) NGL, I'm getting desperate (hoping, praying, wishing doesn't seem to be working lol) and the overwhelm and desire to procrastinate and avoid this is making itself known. Any suggestions, tips, ideas, leads etc would be infinitely appreciated!? submitted by /u/deeplysubmerged [link] [comments]
- One-Minute Daily AI News 2/26/2024by /u/Excellent-Target-847 (Artificial Intelligence) on February 27, 2024 at 5:48 am
Google to relaunch Gemini AI picture generator in a ‘few weeks’ following mounting criticism of inaccurate images. Microsoft Strikes Deal With France’s Mistral, OpenAI Rival. 94% of Indian companies to reskill employees due to impact of AI: LinkedIn. New AI model could streamline operations in a robotic warehouse. Sources:  https://www.cnbc.com/2024/02/26/googles-gemini-ai-picture-generator-to-relaunch-in-a-few-weeks.html  https://www.bloomberg.com/news/articles/2024-02-26/microsoft-strikes-deal-with-france-s-mistral-an-openai-rival-using-open-source?embedded-checkout=true  https://www.business-standard.com/companies/news/94-of-indian-companies-to-reskill-employees-due-to-impact-of-ai-linkedin-124022700228_1.html  https://news.mit.edu/2024/new-ai-model-could-streamline-operations-robotic-warehouse-0227 submitted by /u/Excellent-Target-847 [link] [comments]
- Google's AI (Gemini/Bard) refused to answer my question until I threatened to try Bing.by /u/stuipd (Artificial Intelligence) on February 27, 2024 at 4:35 am
submitted by /u/stuipd [link] [comments]